Regulatory considerations for using surrogate endpoints to accelerate the development of COVID-19 vaccines
YANG Jing-shu
DING Sheng
YANG Yue
Machine-generated Keywords：
Publication Date：2022-01-31
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：6( 119-124 )